Fixed-duration epcoritamab plus R-CHOP for newly diagnosed LBCL with an IPI score of 3 to 5: results from the EPCORE NHL-2 trial
The publisher did not provide an abstract — full text is available via the link below.
The publisher did not provide an abstract — full text is available via the link below.